4-butyrolactone has been researched along with Cell Transformation, Neoplastic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borneman, J; Cheema, AK; Dowdy, T; Fornace, AJ; Maier, I; Ruegger, PM; Schiestl, RH; Singh, R; Wang, Y | 1 |
| Amano, Y; Fukuhara, H; Ishihara, S; Ishimura, N; Kinoshita, Y; Mishima, Y; Sanchez-Siles, AA; Takahashi, Y; Tamagawa, Y; Uno, G; Yuki, T | 1 |
| McCann, MJ; Rowland, IR; Roy, NC | 1 |
| Lupu, R; Mehmi, I; Menendez, JA; Teng, PK; Verma, VA | 1 |
4 other study(ies) available for 4-butyrolactone and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
Chemopreventive Metabolites Are Correlated with a Change in Intestinal Microbiota Measured in A-T Mice and Decreased Carcinogenesis.
Topics: 4-Butyrolactone; Adenine; Animals; Cell Transformation, Neoplastic; Gastrointestinal Microbiome; Intestinal Neoplasms; Mice; Mice, Knockout | 2016 |
Fatty acid synthase expression in Barrett's esophagus: implications for carcinogenesis.
Topics: 4-Butyrolactone; Adenocarcinoma; Aged; Antigens, CD34; Apoptosis; Barrett Esophagus; Bile Acids and Salts; Biopsy; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Chi-Square Distribution; Cyclooxygenase 2; Disease Progression; Enzyme Inhibitors; Esophageal Neoplasms; Esophagoscopy; Fatty Acid Synthase, Type I; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Hydrogen-Ion Concentration; Immunohistochemistry; Japan; Logistic Models; Male; Middle Aged; Odds Ratio; Precancerous Conditions; Proliferating Cell Nuclear Antigen; Risk Assessment; Risk Factors; RNA, Messenger; Time Factors | 2011 |
Anti-proliferative effects of physiological concentrations of enterolactone in models of prostate tumourigenesis.
Topics: 4-Butyrolactone; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; DNA Replication; Humans; Lignans; Male; Mitochondria; Prostatic Neoplasms; Real-Time Polymerase Chain Reaction | 2013 |
Pharmacological inhibition of fatty acid synthase (FAS): a novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformation.
Topics: 4-Butyrolactone; Animals; Antifungal Agents; Apoptosis; Breast Neoplasms; Cell Adhesion; Cell Transformation, Neoplastic; Cells, Cultured; Cerulenin; Chemoprevention; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; fas Receptor; Fatty Acid Synthases; Fatty Acids; Fibroblasts; Gene Expression Regulation, Neoplastic; Humans; In Situ Nick-End Labeling; Mice; Mitogen-Activated Protein Kinases; NIH 3T3 Cells; Phosphatidylinositol 3-Kinases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptor, ErbB-2; Receptors, Tumor Necrosis Factor | 2004 |